OnKure (OKUR) Director Michael G. Grey Receives Award

What Happened
Michael G. Grey, a director of OnKure Therapeutics, was granted a derivative equity award covering 22,350 shares on August 7, 2026. The grant is reported at $0.00 per share (no cash paid) and is coded as an award/grant (A) on the Form 4.

Key Details

• Transaction date: August 7, 2026 — Grant of 22,350 shares @ $0.00 (derivative award).
• Shares owned after transaction: Not specified in the filing provided.
• Vesting note (from filing): 100% of the shares subject to the option will vest on the earlier of June 4, 2027 or the day prior to the issuer’s next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.
• Filing date: August 11, 2026 (filed within the SEC’s two-business-day Form 4 reporting window for an August 7 transaction).

Context
This was a compensation-related derivative award (an option-like grant that vests on a time-based schedule). It is not an open-market purchase or sale and does not indicate an immediate cash outlay or a sale of stock. Grants like this are common for directors as part of compensation and should be viewed as administrative rather than a direct trading signal.